- sales@syndicatedanalytics.com
- +1-213-316-7435
US Insulin Market Research Report and Forecast 2018- 2023
“US Insulin Market Research Report and Forecast 2018- 2023” provides a deep and thorough evaluation of the insulin market in the United States on the basis of drug class (Fast-acting insulin, Intermediate-acting insulin and Long-acting insulin), application (Type 1 diabetes and Type 2 diabetes) and insulin delivery technologies (Injectable insulin, Oral insulin, Inhaled insulin, Other emerging Insulin Delivery Technologies and Insulin pumps). The report also analyses the competitive structure of the US insulin industry and provides the profiles of major players operating in the market.
Beginning with a regional overview, the report explores the dynamics that have a strong influence on the US insulin market and also impact its future growth. Taking 2018 as the base year, the report covers historical market scenario from 2010-2017 and provides forecasts till 2023. This includes the study of value and volume trends as well as pricing history. Growth inducing factors, market restraints and recent developments have also been analyzed in the report in order to provide deeper knowledge about the industry.
US Insulin Market Key Segments
Segmentation by Drug Class
- Fast-Acting Insulin
- Intermediate-Acting Insulin
- Long-Acting Insulin
Segmentation by Application
- Type 1 diabetes
- Type 2 diabetes
Segmentation by Insulin Delivery Technologies
- Injectable Insulin
- Oral Insulin
- Inhaled Insulin
- Other Emerging Insulin Delivery Technologies
- Insulin Pumps
The price margins for the products along with various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the US insulin industry along the parameters of the Porter’s Five Forces model. This model examines the degree of competition in the US insulin market by analyzing the threats posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. SWOT analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the insulin industry. Furthermore, the value chain analysis of the insulin industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing and sales of the products, and their distribution.
Key questions answered in the report include
- What is the historical and current scenario of the US insulin market?
- What are the trends and developments in the US insulin market?
- What is the market forecast of the US insulin market during 2018-2023?
- What is the price analysis and forecast of the insulin market?
- What is the Porter’s five forces analysis of the US insulin market?
- What is the SWOT analysis for the US insulin market?
- What is the value chain analysis of the US insulin market?
The report is a result of exhaustive primary and secondary research undertaken by analysts having years of experience in the insulin industry. All the qualitative and quantitative aspects of the industry have been covered and the collected data has been analyzed and presented in the form of easily comprehensible charts, graphs and tables.
1 Introduction
1.1 Research Objectives
1.2 Stakeholders
1.3 Scope of the Report
1.4 Assumptions and Limitations
2. Research Methodology
2.1. Data Collection
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Validation
3. Executive Summary
4. United States Insulin Market
4.1 Industry Overview
4.2 Key Industry Developments
4.3 Market Trends
4.3.1 Key Market Indicators
4.3.2 Historical Market Trends
4.3.3 Market Forecast
4.4 Price Analysis
4.4.1 Key Price Indicators
4.4.2 Pricing Structure
4.4.3 Historical Price Trends
4.4.4 Price Forecast
4.5 Market Breakup by Drug Class
4.6 Market Breakup by Application
4.7 Market Breakup by Insulin Delivery Technologies
5. United States Insulin Market: Value Chain Analysis
5.1 Overview
5.2 Research and Development
5.3 Raw Material Suppliers
5.4 Inbound Logistics
5.5 Production
5.6 Marketing
5.7 Outbound Logistics
5.8 Consumers
6. United States Insulin Market: SWOT Analysis
6.1 Overview
6.2 Strengths
6.3 Weaknesses
6.4 Opportunities
6.5 Threats
7. United States Insulin Market: Porter’s Five Forces Analysis
7.1 Overview
7.2 Threat of New Entrants
7.3 Threat of Substitutes
7.4 Bargaining Power of Buyers
7.5 Bargaining Power of Suppliers
7.6 Intensity of Rivalry
8. Competitive Landscape
8.1 Market Structure
8.2 Key Players
8.3 Key Success Factors
9. Key Player Profiles
List of Figures
Figure 1: United States: Insulin Market, 2010 - 2017
Figure 2: United States: Insulin Market Forecast, 2018 - 2023
Figure 3: United States: Insulin Market: Price Trends, 2010 - 2017
Figure 4: United States: Insulin Market Forecast: Price Trends, 2018 - 2023
Figure 5: United States: Insulin Market: Breakup by Drug Class, 2017
Figure 6: United States: Insulin Market for Fast-acting Insulin, 2010, 2017 & 2023
Figure 7: United States: Insulin Market for Intermediate-Acting Insulin, 2010, 2017 & 2023
Figure 8: United States: Insulin Market for Long-Acting Insulin, 2010, 2017 & 2023
Figure 9: United States: Insulin Market: Breakup by Application, 2017
Figure 10: United States: Insulin Market for Type 1 diabetes, 2010, 2017 & 2023
Figure 11: United States: Insulin Market for Type 2 diabetes, 2010, 2017 & 2023
Figure 12: United States: Insulin Market: Breakup by Insulin Delivery Technologies, 2017
Figure 13: United States: Insulin Market for Injectable Insulin, 2010, 2017 & 2023
Figure 14: United States: Insulin Market for Oral Insulin, 2010, 2017 & 2023
Figure 15: United States: Insulin Market for Inhaled Insulin, 2010, 2017 & 2023
Figure 16: United States: Insulin Market for Other Emerging Insulin Delivery Technologies, 2010, 2017 & 2023
Figure 17: United States: Insulin Market for Insulin Pumps, 2010, 2017 & 2023
Figure 18: United States: Insulin Industry: Value Chain Analysis
Figure 19: United States: Insulin Industry: SWOT Analysis
Figure 20: United States: Insulin Industry: Porter’s Five Forces Analysis
Figure 21: United States: Insulin Market: Breakup by Key Players, 2017
List of Tables
Table 1: United States: Insulin Industry: Market Summary
Table 2: United States: Insulin Industry: Market Overview, 2017 and 2023
Table 3: United States: Insulin Industry: Market Structure
Table 4: United States: Insulin Market Forecast: Breakup by Drug Class, 2018-2023
Table 5: United States: Insulin Market Forecast: Breakup by Application, 2018-2023
Table 6: United States: Insulin Market Forecast: Breakup by Insulin Delivery Technologies, 2018-2023
Table 7: United States: Insulin Market: Key Player
Special Prices
- Academic Institutes
- Government Agencies
- Nonprofit Organizations
- For more information, feel free to contact us.
Syndicated Analytics provides special pricing for:
Related Reports
The report offers an in-depth roadmap or setting up a sanitary napkins manufacturing plant covering the essential techno-commercial aspects. It offers insight into the sanitary napkins production process, covering key success and risk factors for manufacturers, process flow, reactions involved, ra...
The report offers an in-depth roadmap or setting up a surgical gloves manufacturing plant covering the essential techno-commercial aspects. It offers insight into the surgical gloves production process, covering key success and risk factors for manufacturers, process flow, reactions involved, raw ...
This production cost analysis report by Syndicated Analytics is the result of comprehensive examination of the Linear Alkylbenzene Sulfonate manufacturing process
The GCC Healthcare Information Software Market was worth US$ XX Billion in 2019, expanding at a CAGR of X% during 2012-2019. The market is projected to register a CAGR of X% during 2020-2025, reaching US$ XX Billion by 2025.
The GCC Body Contouring was worth US$ XX Billion in 2019, expanding at a CAGR of X% during 2012-2019. The market is projected to register a CAGR of X% during 2020-2025, reaching US$ XX Billion by 2025.